NIRVANA DRUG AND ALCOHOL TREATMENT PROGRAM (EIN 770457436) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1997

Legal Domicile

Phone

2095791151

Tax Period

2023-09-01 to 2024-08-31

NIRVANA DRUG AND ALCOHOL TREATMENT PROGRAM, founded in 1997, is a community nonprofit in the Human Services sector that reported $3.9M in total revenue in fiscal year 2023. Revenue surged 25% from the prior year, signaling strong growth momentum. The organization ran a surplus of $900K, a strong 23% operating margin.

Mission

TO IMPROVE THE LIVES OF ALL CHEMICALLY ADDICTED INDIVIDUALS AND THEIR FAMILIIES IN THE CENTRAL VALLEY OF CALIFORNIA BY TREATING OUR CLIENTS WITH INTEGRITY AND COMPASSION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $3,820,662

Investment Income $81

Other Revenue $33,750

TOTAL REVENUE $3,854,493

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,758,654

Fundraising Expenses $0

Program Expenses $2,303,413

Other Expenses $1,195,605

TOTAL EXPENSES $2,954,259

Year-over-Year Comparison

	2023	2022	Change
Revenue	$3,854,493	$3,077,104	+0.3%
Expenses	$2,954,259	$2,564,530	+0.2%
Net Income	$900,234	$512,574	+0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$21,050

Total Directors

$296,575

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DANE HELDING	BOARD MEMBER	40.00	Director	$144,033	$0	$144,033
MIKE BAGLEY	BOARD MEMBER	40.00	Director	$131,492	$0	$131,492
DAVID KIRKLAND	Vice President	0.00	Officer Director	$21,050	$0	$21,050
MICHAEL MILLER	BOARD MEMBER	0.00	Director	$0	$0	$0
TROY ROSE	President	0.00	Officer Director	$0	$0	$0
WAYNE DAVISON	BOARD MEMBER	0.00	Director	$0	$0	$0
ROBERT BAGLEY	BOARD MEMBER	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$3,854,493	$2,954,259	$2,753,070	$900,234
2023	$3,077,104	$2,564,530	$2,090,693	$512,574
2022	$2,435,439	$2,485,382	$1,308,100	$-49,943
2021	$2,235,095	$2,300,176	$1,365,763	$-65,081
2020	$2,718,016	$2,321,295	$1,538,371	$396,721
2019	$1,634,247	$1,879,515	$998,589	$-245,268

NIRVANA DRUG AND ALCOHOL TREATMENT PROGRAM